Charles Harris

Edge Rusher

Age: 29
Free Agency: 2025 (UFA)
Accrued Seasons: 7
  • 2024 Salary Cap Charge: $328,333 (0.13% of cap)
  • 2024 Cash Payout: $403,333 (0.13% of spending)
  • 2024 Cash to Cap Ratio: 1.23
  • Contract Value: $1,210,000 ($1,210,000 APY)
  • Fully Guaranteed Money: $0
  • Contract Ranking: 128/245 at EDGE

Current Contract

(SFA, signed 2024)
(📝: indicates contract trigger occuring during that year)
YearAgeBase SalaryCap
Number
Cap %
Dead Money & Cap Savings
202429$1,210,000$328,3330.1%
Total$1,210,000$328,333

Contract Notes

Charles Harris signed a two year, $13 million contract with the Lions. $7 million is guaranteed including a $5.965M signing bonus. There is a void year for cap purposes.

Cash Flows

- fully earned money
- unearned or partially earned money
$1.2M
2024
Cash Due$1,210,000
Running Cash$1,210,000
Career Earnings: $23,715,774
Career APY: $3,387,968
Potential Earnings: $23,379,662
Total Guarantees: $32,854,834
Largest Cash Payment: $7,000,000 (2022)
Largest Cap Number: $5,385,392 (2023)

Contract History

TeamContract TypeStatusYear SignedYrsTotalAPYGuaranteesAmount Earned% EarnedEffective APY
DolphinsDraftedTraded20174$10,843,976$2,710,994$10,552,417$8,900,25282.1%$2,966,751
FalconsDraftedExpired20174$10,843,976$2,710,994$10,552,417$1,943,72417.9%$1,943,724
LionsUFAExpired20211$1,750,000$1,750,000$1,750,000$1,750,000100.0%$1,750,000
LionsUFARenegotiated20222$13,000,000$6,500,000$7,000,000$7,000,00053.8%$7,000,000
LionsOtherExpired20231$3,500,000$3,500,000$3,000,000$3,382,35396.6%$3,382,353
PanthersSFAClaimed20241$1,210,000$1,210,000$0$00.0%$0
EaglesSFAActive20241$1,210,000$1,210,000$0$00.0%$0
Earnings By Team
TeamYrsSalaryAPYPaid on Cap% Paid on CapPaid as Dead Money% Paid as Dead Money
Dolphins3$8,900,252$2,966,751$7,393,6200.0%$1,506,6320.0%
Falcons1$1,943,724$1,943,724$1,943,7240.0%$00.0%
Lions3$12,132,353$4,044,118$10,158,7250.0%$1,988,3340.0%
Panthers0$739,445$0$00.0%$601,9450.0%
Eagles0$0$0$00.0%$00.0%

Season History

YearTeamBase SalaryProrated BonusPer Game Roster BonusGuaranteed SalaryCap
Number
Cap %Cash Paid
2017Dolphins$465,000$1,506,632$0$465,000$1,971,6321.1%$6,491,528
2018Dolphins$957,908$1,506,632$0$957,908$2,464,5401.4%$957,908
2019Dolphins$1,450,816$1,506,632$0$1,450,816$2,957,4481.5%$1,450,816
2020Falcons$1,943,724$0$0$1,652,165$1,943,7241.0%$1,943,724
2021Lions$1,400,000$350,000$0$1,400,000$1,750,0000.9%$1,750,000
2022Lions$1,035,000$1,988,333$0$1,035,000$3,023,3331.4%$7,000,000
2023Lions$3,000,000$1,988,333$500,000$3,000,000$5,385,3922.4%$3,382,353
2024Eagles$1,210,000$0$0$0$328,3330.1%$403,333
Total$11,462,448$8,846,562$500,000$9,960,889$19,824,402$23,379,662
Dead Money History
TeamYearCap ChargeCash Paid
Dolphins2020$1,506,632$0
Lions2024$1,988,334$0
Panthers2024$601,945$739,445
Total$4,096,911$739,445

Statistics

YearGames PlayedGames InactiveSnapsTacklesNegative PlaysInterceptionsFumblesTD
InjuredHealthyDefenseSpecialSoloAssistSacksYardsTFLQB HitsPass Def.INTYardsForcedRec.Yards
2017160047.4%14.1%1542115122000100
2018115031.8%15.4%81112250000000
2019140238.6%4.7%11120.53.5360000000
2020132126.8%13.1%89318352000000
2021170076.4%22.9%34317.57010160002000
202262323.0%6.5%10415241001000
2023130426.6%11.2%1031.512.5250000000
202490148.8%16.6%146318470000000

Valuation Diamond

The diamond is a scatterplot graph that visualizes the relation of the player's APY (in green) and performance (in blue, as measured by OTC's Valuations) to the rest of the league at his position. To understand how to read the diamond, read this explainer.

OTC ValuationAPY
Regular$4,273,000$1,210,000
Injury Adjusted$4,273,000$1,210,000
test
OTC Valuation $4.8M $9.6M $14.4M $19.3M $24.1M APY $5.7M $11.3M $17M $22.7M $28.3M $10,098,000 $10,000,000

Weekly Valuation Trends

The chart below illustrates the trend of the player's weekly OTC Valuations (in blue) from the most recent season, using APY (in green) and, if applicable, cash that is due to the player in the next season (in red) as benchmarks. Weeks not plotted indicate that the player was inactive or on a bye.

To see interactive and more in-depth use of OTC Valuation data, subscribe to OTC Premium.